GPNMB Positive
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery (NCT03326258) | National Cancer Institute (NCI) | 2018-04-20 |
Track GPNMB Positive automatically
Every clearance here is in the API, with alerts when new ones post.